CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 796.00
+45.00 (5.99%)
Jul 15, 2026, 3:30 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 15.21 billion as of July 15, 2026. Its market cap has decreased by -16.39% in one year.
Market Cap
15.21B
Enterprise Value
13.45B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
796.00
Market Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 15.21B, an increase of 81.48%. That is a compound annual growth rate of 3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 15.21B | -0.87% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renascience | 21.45B |
| AnGes | 19.94B |
| StemRIM | 18.99B |
| RaQualia Pharma | 12.81B |
| SUSMED,Inc. | 12.27B |
| ReproCELL | 12.16B |
| Stella Pharma | 12.14B |
| Kubota Pharmaceutical Holdings | 10.86B |